teleo-codex/domains/health/_map.md

Health & Human Flourishing

Vida's domain spans the structural transformation of healthcare from reactive sick care to proactive health management. Two layers: the industry analysis (where value concentrates, which business models win, what regulations shape the transition) and the civilizational argument (healthspan as infrastructure that enables everything else). Healthcare consumes 18% of US GDP while producing declining life expectancy — a system that profits from sickness rather than health.

Attractor State

• the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness — the full attractor state derivation: five convergent layers, moderate-to-strong attractor
• healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create — three-layer model for where value accrues in the transition
• Function Health drives down diagnostic conversion costs to 499 per year for 100-plus lab tests making atoms-to-bits health data generation accessible at consumer scale — atoms-to-bits at the diagnostics conversion point

Biometrics & Continuous Monitoring

• continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware — the attractor state architecture for health monitoring: 4 sensor layers unified by AI
• AI middleware bridges consumer wearable data to clinical utility because continuous data is too voluminous for direct clinician review — the integration gap between consumer data and clinical workflows
• consumer CGMs are going mainstream as behavioral change tools not clinical diagnostics because real-time glucose visibility changes food choices even without randomized trial evidence — OTC CGM transition from medical device to wellness tool
• the FDA now separates wellness devices from medical devices based on claims not sensor technology enabling health insights without full medical device classification — regulatory framework enabling the wellness-to-clinical spectrum
• Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth — category-dominant smart ring with patent moat and demographic expansion
• WHOOP subscription-only wearable model generates $260M revenue but trails Oura at half the revenue and a third the valuation because fitness-first positioning limits the addressable wellness market — subscription-only wearable testing fitness-first positioning

AI in Clinical Care

• healthcare AI creates a Jevons paradox because adding capacity to sick care induces more demand for sick care — AI optimizing the 10-20% clinical side while 80-90% of outcomes are non-clinical
• AI diagnostic triage achieves 97 percent sensitivity across 14 conditions making AI-first screening viable for all imaging and pathology — Aidoc, Viz.ai, DermaSensor evidence
• the physician role shifts from information processor to relationship manager as AI automates documentation triage and evidence synthesis — PwC $1T spending shift projection
• ambient AI documentation reduces physician documentation burden by 73 percent but the relationship between automation and burnout is more complex than time savings alone — Abridge, DAX Copilot, Epic AI Charting
• OpenEvidence became the fastest-adopted clinical technology in history reaching 40 percent of US physicians daily within two years — AI clinical decision support as beachhead
• medical LLM benchmark performance does not translate to clinical impact because physicians with and without AI access achieve similar diagnostic accuracy in randomized trials — the benchmark-to-clinical gap
• human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs — physician overrides degrade AI from 90% to 68%
• healthcare AI regulation needs blank-sheet redesign because the FDA drug-and-device model built for static products cannot govern continuously learning software — Wachter's physician-licensing model for AI regulation

Value-Based Care & Social Determinants

• value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk — the gap between VBC participation and actual risk-bearing
• healthcare is a complex adaptive system requiring simple enabling rules not complicated management because standardized processes erode the clinical autonomy needed for value creation — Porter/Larsson framework connecting VBC to complexity science
• SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action — the SDOH implementation gap
• four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable — structural landscape of healthcare delivery
• medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm — evidence base for why VBC and SDOH matter

Drug Discovery & New Therapeutics

• AI compresses drug discovery timelines by 30-40 percent but has not yet improved the 90 percent clinical failure rate that determines industry economics — AI drug discovery: proven speed, unproven efficacy
• GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035 — GLP-1 economics: $63-70B market, oral breakthrough, durability problem
• gene editing is shifting from ex vivo to in vivo delivery via lipid nanoparticles which will reduce curative therapy costs from millions to hundreds of thousands per treatment — scalability breakthrough for curative medicine
• personalized mRNA cancer vaccines show sustained 49 percent reduction in melanoma recurrence after five years representing a genuinely novel therapeutic paradigm — mRNA platform beyond COVID
• the healthcare cost curve bends up through 2035 because new curative and screening capabilities create more treatable conditions faster than prices decline — net cost trajectory: inflationary through transition

Mental Health & Digital Therapeutics

• prescription digital therapeutics failed as a business model because FDA clearance creates regulatory cost without the pricing power that justifies it for near-zero marginal cost software — Pear, Akili, Woebot: the DTx autopsy
• the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access — structural workforce deficit
• social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem — loneliness as public health crisis

Capital & Market Dynamics

• healthcare AI funding follows a winner-take-most pattern with category leaders absorbing capital at unprecedented velocity while 35 percent of deals are flat or down rounds — bifurcated VC landscape

Regulatory

• CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring — CMS targeting acquisition-based vertical integration
• anti-payvidor legislation targets all insurer-provider integration without distinguishing acquisition-based arbitrage from purpose-built care delivery — structural separation bills threatening payvidor model
• Kaiser Permanentes 80-year tripartite structure is the strongest precedent for purpose-built payvidor exemptions because any structural separation bill that captures Kaiser faces 12.5 million members and Californias entire healthcare infrastructure — Kaiser's 80-year precedent for purpose-built integration

Epidemiological Transition & Risk Landscape

• the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations — the fundamental discontinuity
• Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s — US life expectancy reversing
• Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated — food industry creating disease
• modernization dismantles family and community structures replacing them with market and state relationships that increase individual freedom but erode psychosocial foundations of wellbeing — dissolved social structures
• famine disease and war are products of the agricultural revolution not immutable features of human existence and specialization has converted all three from unforeseeable catastrophes into preventable problems — historical context for health transition